Buy Bevacizumab Injection 400 mg/16 mL Online
Therapeutic Uses
Bevacizumab Injection may be prescribed for selected patients with:
- Metastatic colorectal cancer
- Non-small cell lung cancer (NSCLC)
- Glioblastoma
- Metastatic renal cell carcinoma
- Persistent or recurrent cervical cancer
- Ovarian, fallopian tube, and primary peritoneal cancers
- Hepatocellular carcinoma (in approved combination regimens)
The indication depends on local regulatory approval and the treating oncologist's recommendation.
Recommended Dosage
The dose is not fixed at 400mg per patient.
Treatment is generally calculated according to body weight (mg/kg) and the specific cancer being treated.
Typical dosing schedules include administration every 2 or 3 weeks, depending on the approved treatment protocol and combination therapy.
Only trained healthcare professionals should determine the appropriate dose, infusion duration, and treatment interval.
Medicine
Bevacizumab Injection 400mg/16mL is a monoclonal antibody used in targeted cancer therapy. Unlike conventional chemotherapy, bevacizumab acts on the blood vessels that nourish tumors. It is administered by intravenous infusion under the supervision of qualified oncology professionals and is frequently combined with other anticancer medicines depending on the patient's diagnosis.
How Bevacizumab Works
Cancer cells require a continuous blood supply to receive oxygen and nutrients. Bevacizumab blocks vascular endothelial growth factor (VEGF), a protein responsible for stimulating the formation of new blood vessels. By preventing new vessel growth (angiogenesis), the medicine limits the tumor's blood supply, helping slow disease progression.
Global Oncology Biologic Supplier & Exporter: United States, Washington, D.C.; United Kingdom, London; Germany, Berlin; France, Paris; Italy, Rome; Spain, Madrid; Netherlands, Amsterdam; Belgium, Brussels; Switzerland, Bern; Poland, Warsaw; Hungary, Budapest; Australia, Canberra; New Zealand, Wellington; Singapore; Malaysia, Kuala Lumpur; Indonesia, Jakarta; Vietnam, Hanoi; Philippines, Manila; Thailand, Bangkok. United Arab Emirates, Abu Dhabi; Saudi Arabia, Riyadh; Qatar, Doha; Oman, Muscat; Kuwait, Kuwait City; South Africa, Pretoria; Nigeria, Abuja; Peru, Lima; Argentina, Buenos Aires; Brazil, Brasília; Mexico, Mexico City; Chile, Santiago; Colombia, Bogotá.
Demand for Targeted Cancer Biologics Continues to Expand Worldwide
The global oncology sector continues to increase procurement of targeted biological medicines such as Bevacizumab Injection 400 mg/16 mL. Hospitals and cancer treatment centers are seeking reliable pharmaceutical exporters capable of providing consistent product quality, manufacturer documentation, and dependable international logistics for institutional procurement.
📞 Contact Ernest Oncology – Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.]
🌐 Websites:
www.ernestimpex.com
www.oncologuymediciensupplier.com
www.ernestvision.com
📧 Email: exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
Frequently Asked Questions
1. What type of medicine is Bevacizumab?
It is a targeted monoclonal antibody used in the treatment of several cancers.
2. Is the 400mg vial a single patient dose?
Not necessarily. The required dose depends on the patient's body weight and treatment protocol.
3. Can hospitals purchase Bevacizumab in bulk?
Yes. Licensed hospitals, distributors, and government procurement agencies may request commercial quotations.
4. What should be done if a treatment session is missed?
The patient should contact the oncology center promptly to arrange a new infusion appointment.
5. Is Bevacizumab administered at home?
No. It is administered by qualified healthcare professionals in hospitals or specialized infusion centers.
